Finally, trials stopped early are likely to be of small size, and as a consequence their results may lack both statistical precision and credibility, since medical community might remain sceptical, even in case of highly significant results.
← all excerpts
Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: a survey from the Italian National Monitoring Centre for Clinical Trials.
1
—
—